Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70133 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Hélène Peyrière und 13 weiteren Autor:innen. Beteiligte Einrichtung: Addictovigilance Centre, Montpellier University Hospital, France. Hauptthemen laut MEDLINE: Psychotropic Drugs, Pharmacovigilance, Substance-Related Disorders. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MILDECA (Mission Interministérielle de Lutte contre les Conduites Addictives), Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents.
Methods
Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Addictovigilance Centre, Montpellier University Hospital, France.
- INSERM U 1058, Pathogenesis and Control of Chronic Infections (PCCI), Montpellier, France.
- Addictovigilance Centre, AP-HP (Paris Public Hospitals), Paris, France.
- Addictovigilance Centre, Grenoble-Alpes University Hospital, France.
- Addictovigilance Centre, Bordeaux University Hospital, France.
- Addictovigilance Centre, Clermont-Ferrand University Hospital, France.
ORCID-Profile: Amélie Daveluy, Emilie Jouanjus
Förderung
- MILDECA (Mission Interministérielle de Lutte contre les Conduites Addictives)
- Mission Interministérielle de Lutte Contre les Drogues et les Conduites Addictives
Zitieren
APA
Peyrière, H., Batisse, A., Sam-Laï, N. F., Daveluy, A., Fournier-Choma, C., Deheul, S., Chevalier, C., Lacroix, C., Gibaja, V., Aquizerate, A., Pain, S., Jouanjus, E., Picot, M. C., & Nogue, E. (2025). Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70133
Vancouver
Peyrière H, Batisse A, Sam-Laï NF, Daveluy A, Fournier-Choma C, Deheul S, et al. Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70133
BibTeX
@article{Peyrire2025,
author = {Peyrière, Hélène and Batisse, Anne and Sam-Laï, Nathalie Fouilhé and Daveluy, Amélie and Fournier-Choma, Christine and Deheul, Sylvie and Chevalier, Cécile and Lacroix, Clémence and Gibaja, Valérie and Aquizerate, Aurélie and Pain, Stéphanie and Jouanjus, Emilie and Picot, Marie-Christine and Nogue, Erika},
title = {Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70133}
}
EUVIMED